A citation-based method for searching scientific literature

Jaclyn F Hechtman, Ryma Benayed, David M Hyman, Alexander Drilon, Ahmet Zehir, Denise Frosina, Maria E Arcila, Snjezana Dogan, David S Klimstra, Marc Ladanyi, Achim A Jungbluth. Am J Surg Pathol 2017
Times Cited: 195



Zoran Gatalica, Joanne Xiu, Jeffrey Swensen, Semir Vranic. Mod Pathol 2019
Times Cited: 183




List of shared articles



Times cited

Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
Iva Brčić, Theresa Maria Godschachner, Marko Bergovec, Jasminka Igrec, Holger Till, Herwig Lackner, Susanne Scheipl, Karl Kashofer, Thomas Brodowicz, Andreas Leithner,[...]. Mod Pathol 2021
11

Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial.
Koen De Winne, Laure Sorber, Suzan Lambin, Vasiliki Siozopoulou, Gabriela Beniuga, Franceska Dedeurwaerdere, Nicky D'Haene, Lionel Habran, Louis Libbrecht, Jacques Van Huysse,[...]. Virchows Arch 2021
3

NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms.
Sabrina Croce, Isabelle Hostein, W Glenn McCluggage. Genes Chromosomes Cancer 2021
3

Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer.
Esther Conde, Susana Hernandez, Elena Sanchez, Rita Maria Regojo, Carmen Camacho, Marta Alonso, Rebeca Martinez, Fernando Lopez-Rios. Arch Pathol Lab Med 2021
2

Chromosomal imbalances detected in NTRK-rearranged sarcomas by the use of comparative genomic hybridisation.
Ana Cristina Vargas, Nima M Ardakani, Daniel D Wong, Fiona M Maclean, Joseph Kattampallil, Richard Boyle, Leonardo Santos, Anthony J Gill. Histopathology 2021
1

Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.
Shaham Beg, Rohan Bareja, Kentaro Ohara, Kenneth Wha Eng, David C Wilkes, David J Pisapia, Wael Al Zoughbi, Sarah Kudman, Wei Zhang, Rema Rao,[...]. Transl Oncol 2021
1

[Diagnosis and therapy of tumors with NTRK gene fusion].
Albrecht Stenzinger, Cornelis M van Tilburg, Ghazaleh Tabatabai, Florian Länger, Norbert Graf, Frank Griesinger, Lukas C Heukamp, Michael Hummel, Thomas Klingebiel, Simone Hettmer,[...]. Pathologe 2021
1


Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
Hidetaka Yamamoto, Yui Nozaki, Azusa Sugii, Kenichi Taguchi, Takahiro Hongo, Rina Jiromaru, Masanobu Sato, Takafumi Nakano, Kazuki Hashimoto, Minako Fujiwara,[...]. Hum Pathol 2021
1

Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer.
Hedvig Elfving, Erika Broström, Lotte N J Moens, Jonas Almlöf, Dijana Cerjan, Gilbert Lauter, Helena Nord, Johanna S M Mattsson, Gustav J Ullenhag, Carina Strell,[...]. Lung Cancer 2021
3

Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing.
Jinjuan Yao, Maria E Arcila, Marc Ladanyi, Jaclyn F Hechtman. Arch Pathol Lab Med 2021
1

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.
Sébastien Perreault, Rose Chami, Rebecca J Deyell, Dina El Demellawy, Benjamin Ellezam, Nada Jabado, Daniel A Morgenstern, Aru Narendran, Poul H B Sorensen, Jonathan D Wasserman,[...]. Curr Oncol 2021
3

Neurofibrosarcoma Revisited: An Institutional Case Series of Uterine Sarcomas Harboring Kinase-related Fusions With Report of a Novel FGFR1-TACC1 Fusion.
Kelly A Devereaux, Julianna J Weiel, Anne M Mills, Christian A Kunder, Teri A Longacre. Am J Surg Pathol 2021
2

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours.
P Garrido, R Hladun, E de Álava, R Álvarez, F Bautista, F López-Ríos, R Colomer, F Rojo. Clin Transl Oncol 2021
2

NTRK fusion in Japanese colorectal adenocarcinomas.
Yuya Yamashiro, Taisei Kurihara, Takuo Hayashi, Yoshiyuki Suehara, Takashi Yao, Shunsuke Kato, Tsuyoshi Saito. Sci Rep 2021
2

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
Ruiying Zhao, Feng Yao, Chan Xiang, Jikai Zhao, Zhanxian Shang, Lianying Guo, Wenjie Ding, Shengji Ma, Anbo Yu, Jinchen Shao,[...]. J Pathol Clin Res 2021
1

NTRK fusions and Trk proteins: what are they and how to test for them.
Lawrence M Weiss, Vincent A Funari. Hum Pathol 2021
2

[How to test for NTRK gene fusions: A practical approach for pathologists].
Arnaud Uguen, Marie Csanyi-Bastien, Jean-Christophe Sabourin, Frédérique Penault-Llorca, Julien Adam. Ann Pathol 2021
0

Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
Marie Csanyi-Bastien, Marie-Delphine Lanic, Ludivine Beaussire, Sandra Ferric, Arnaud François, Didier Meseure, Fabrice Jardin, Michel Wassef, Philippe Ruminy, Marick Laé. Am J Surg Pathol 2021
0

Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma.
Simon Strohmeier, Iva Brcic, Helmut Popper, Bernadette Liegl-Atzwanger, Jörg Lindenmann, Luka Brcic. Sci Rep 2021
1

Updates in the molecular pathology of non-small cell lung cancer.
Elizabeth Paver, Sandra O'Toole, Xin Min Cheng, Annabelle Mahar, Wendy A Cooper. Semin Diagn Pathol 2021
0

MLH1/PMS2 Expression Could Tell Classical NTRK Fusion in Fluorescence In Situ Hybridization Positive Colorectal Carcinomas.
Yao Fu, Zheng Li, Fuping Gao, Jun Yang, Hongyan Wu, Biao Zhang, Xiaohong Pu, Xiangshan Fan. Front Oncol 2021
0

A Brief Overview and Update on Major Molecular Genomic Alterations in Solid, Bone and Soft Tissue Tumors, and Hematopoietic As Well As Lymphoid Malignancies.
Wei Zhang, Jinjuan Yao, Minghao Zhong, Yaxia Zhang, Xiaoling Guo, Huan-You Wang. Arch Pathol Lab Med 2021
0

0

NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Jung Ho Kim, Jeong Hoon Hong, Yoon-La Choi, Ji Ae Lee, Mi-Kyoung Seo, Mi-Sook Lee, Sung Bin An, Min Jung Sung, Nam-Yun Cho, Sung-Su Kim,[...]. J Pathol 2021
0

Molecular Testing in Breast Cancer: Current Status and Future Directions.
Lulu Sun, Ariel Wu, Gregory R Bean, Ian S Hagemann, Chieh-Yu Lin. J Mol Diagn 2021
0

Novel fusion sarcomas including targetable NTRK and ALK.
Tiane Chen, Ying Wang, Lianna Goetz, Zachary Corey, Meaghan C Dougher, Jessica D Smith, Edward J Fox, Andrew S Freiberg, Donald Flemming, Julie C Fanburg-Smith. Ann Diagn Pathol 2021
0

NTRK fusions in colorectal cancer: clinical meaning and future perspective.
Margherita Ratti, Giulia Grizzi, Rodolfo Passalacqua, Andrea Lampis, Fabrizio Cereatti, Roberto Grassia, Jens Claus Hahne. Expert Opin Ther Targets 2021
0

Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma.
Shafei Wu, Xiaohua Shi, Xinyu Ren, Kaimi Li, Junyi Pang, Zhiyong Liang. Front Mol Biosci 2021
0

Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
Amélie Bourhis, Charline Caumont, Isabelle Quintin-Roué, Elsa Magro, Gurvan Dissaux, Annabelle Remoué, Pierre Le Noac'h, Nathalie Douet-Guilbert, Romuald Seizeur, Alexandra Tyulyandina,[...]. Pathology 2021
0

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
Luiza N Weis, Sara M Tolaney, Carlos H Barrios, Romualdo Barroso-Sousa. NPJ Breast Cancer 2021
0

[Multidisciplinary consensus on optimizing the detection of NTRK gene alterations in tumours].
Federico Rojo, Ramón Colomer, Fernando López-Ríos, Francisco Bautista, Rosa Álvarez, Enrique de Álava, Raquel Hladun, Pilar Garrido. Rev Esp Patol 2021
0

Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing.
Jing Wang, Ruiyu Li, Junjie Li, Yuting Yi, Xiaoding Liu, Jingci Chen, Hui Zhang, Junliang Lu, Cami Li, Huanwen Wu,[...]. J Transl Med 2021
0

The oncogenic roles of NTRK fusions and methods of molecular diagnosis.
Erfan Aref-Eshghi, Fumin Lin, Marilyn M Li, Yiming Zhong. Cancer Genet 2021
0

[A NTRK1-rearranged mammary carcinoma].
Annabelle Remoué, Virginie Conan-Charlet, Glen Le Flahec, Laetitia Lambros, Pascale Marcorelles, Arnaud Uguen. Ann Pathol 2020
0

Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
Derek Wong, Stephen Yip, Poul H Sorensen. Pathol Oncol Res 2020
17

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
James P Solomon, Irina Linkov, Andrea Rosado, Kerry Mullaney, Ezra Y Rosen, Denise Frosina, Achim A Jungbluth, Ahmet Zehir, Ryma Benayed, Alexander Drilon,[...]. Mod Pathol 2020
142

Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.
Bin Xu, Mohamed R Haroon Al Rasheed, Cristina R Antonescu, Deepu Alex, Denise Frosina, Ronald Ghossein, Achim A Jungbluth, Nora Katabi. Histopathology 2020
25

Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature.
Jerzy Lasota, Małgorzata Chłopek, Jennifer Lamoureux, Jason Christiansen, Artur Kowalik, Bartosz Wasąg, Anna Felisiak-Gołąbek, Abbas Agaimy, Wojciech Biernat, Vincenzo Canzonieri,[...]. Am J Surg Pathol 2020
27

Diagnostic utility of pan-Trk immunohistochemistry for inflammatory myofibroblastic tumours.
Hidetaka Yamamoto, Yui Nozaki, Kenichi Kohashi, Izumi Kinoshita, Yoshinao Oda. Histopathology 2020
8

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
P Garrido, E Conde, J de Castro, J J Gómez-Román, E Felip, L Pijuan, D Isla, J Sanz, L Paz-Ares, F López-Ríos. Clin Transl Oncol 2020
22

Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
Nicole Pfarr, Martina Kirchner, Ulrich Lehmann, Jonas Leichsenring, Sabine Merkelbach-Bruse, Julia Glade, Michael Hummel, Fabian Stögbauer, Annika Lehmann, Marcel Trautmann,[...]. Genes Chromosomes Cancer 2020
28

NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases.
Angela Chou, Tamara Fraser, Mahsa Ahadi, Talia Fuchs, Loretta Sioson, Adele Clarkson, Amy Sheen, Nisha Singh, Christopher L Corless, Anthony J Gill. Mod Pathol 2020
24


NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
Joseph T Rabban, W Patrick Devine, Ankur R Sangoi, Liina Poder, Edwin Alvarez, Jessica L Davis, Erin Rudzinski, Karuna Garg, Gregory R Bean. Histopathology 2020
21

NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.
Alessandro Gambella, Rebecca Senetta, Giammarco Collemi, Stefano Gabriele Vallero, Matteo Monticelli, Fabio Cofano, Pietro Zeppa, Diego Garbossa, Alessia Pellerino, Roberta Rudà,[...]. Int J Mol Sci 2020
23

[NTRK Fusions: A new way of treatment for gastro-intestinal tumor?]
Kaïssa Ouali, Anna Pellat, Romain Cohen, Magali Svrcek, Frédérique Penault-Llorca, Thierry André. Bull Cancer 2020
1

EPR17341 and A7H6R pan-TRK Immunohistochemistry Result in Highly Different Staining Patterns in a Series of Salivary Gland Tumors.
Briac Guibourg, Emma Cloarec, Virginie Conan-Charlet, Isabelle Quintin-Roué, Jean-Luc Grippari, Glen Le Flahec, Pascale Marcorelles, Arnaud Uguen. Appl Immunohistochem Mol Morphol 2020
6

TRK inhibition in soft tissue sarcomas: A comprehensive review.
Tarek Assi, Elie Rassy, Hussein Nassereddine, Fadi Farhat, Fadi El Karak, Joseph Kattan, Marwan Ghosn. Semin Oncol 2020
5